Clinical Trial Update: Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma [Phase 1]

View source ↗

Summary

A Phase I trial evaluating P276-00 for safety and efficacy in subjects with multiple myeloma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• P276-00 (P276-00)

Snippet

Sponsor: Piramal Enterprises Limited | Conditions: Multiple Myeloma | Phase 1 | Status: WITHDRAWN